Facebook Linkedin RSS Twitter Youtube
Home 2019

Chronic obstructive pulmonary disease

Bayer Joins Brigham and Women’s, Mass General to Create Lab for Chronic Lung Disease R&D
Industry News

Bayer Joins Brigham and Women’s, Mass General to Create Lab for Chronic Lung Disease R&D

Novartis Gains Option to Acquire Second IFM Subsidiary in Up-to-$840M cGAS/STING Collaboration
Drug Discovery

Novartis Gains Option to Acquire Second IFM Subsidiary in Up-to-$840M cGAS/STING Collaboration

Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Drug Discovery

Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App

Link between Celiac Disease, Cystic Fibrosis May Lead to Gluten Intolerance Drugs
Drug Discovery

Link between Celiac Disease, Cystic Fibrosis May Lead to Gluten Intolerance Drugs

Bioengineering Breath
Insights

Bioengineering Breath

Cannabis Doesn’t Help Exercising COPD Patients
News

Cannabis Doesn’t Help Exercising COPD Patients

After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans for Fasenra
Drug Discovery

After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans for Fasenra

IL-26 Offers New Therapeutic Target for Chronic Smokers with Lung Disease
Drug Discovery

IL-26 Offers New Therapeutic Target for Chronic Smokers with Lung Disease

AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
Drug Discovery

AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure

Beyond Repurposing: The Case for Creating New Chemical Entities by Modifying Existing Molecules
Insights

Beyond Repurposing: The Case for Creating New Chemical Entities by Modifying Existing Molecules

1234...14Page 3 of 14
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.